本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Emergent Biosolutions

5.64
+0.46008.88%
盤後5.54-0.1020-1.81%17:50 EDT
成交量:136.22萬
成交額:754.74萬
市值:2.89億
市盈率:-1.67
高:5.67
開:5.20
低:5.20
收:5.18
52周最高:14.06
52周最低:4.36
股本:5,127.33萬
流通股本:4,837.27萬
量比:1.11
換手率:2.82%
股息:- -
股息率:- -
每股收益(TTM):-3.3870
每股收益(LYR):0.9300
淨資產收益率:-40.29%
總資產收益率:6.93%
市淨率:0.85
市盈率(LYR):6.06

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/31

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/29

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/29

重要事件披露

Form 8-K - Current report
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/17

重要事件披露

Form 8-K - Current report
2026/04/10

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

重要事件披露

Form 8-K - Current report